Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation

被引:33
|
作者
Barter, Matt J. [1 ]
Hui, Wang [2 ]
Lakey, Rachel L. [1 ]
Catterall, John B. [3 ]
Cawston, Tim E. [1 ]
Young, David A. [1 ]
机构
[1] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Newcastle Univ, Sch Med, Dept Rheumatol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Duke Univ, Dept Med, Durham, NC USA
关键词
SMOOTH-MUSCLE-CELLS; BOVINE NASAL CARTILAGE; NECROSIS-FACTOR-ALPHA; ONCOSTATIN-M; RHEUMATOID-ARTHRITIS; IN-VITRO; THERAPEUTIC TARGETS; MURINE MODEL; SIMVASTATIN; OSTEOARTHRITIS;
D O I
10.1136/ard.2010.129197
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate if statins prevent cartilage degradation and the production of collagenases and gelatinases in bovine nasal and human articular cartilage after proinflammatory cytokine stimulation. Methods In a cartilage degradation model, the effects of several statins were assessed by measuring proteoglycan degradation and collagen degradation, while collagenolytic and gelatinolytic activity in culture supernatants were determined by collagen bioassay and gelatin zymography. The production of matrix metalloproteinases (MMPs) in cartilage and chondrocytes were analysed by real-time reverse transcriptase PCR and immunoassay. Cytokine-induced signalling pathway activation was studied by immunoblotting. Results Simvastatin and mevastatin significantly inhibited interleukin 1 (IL-1) + oncostatin M (OSM)-induced collagen degradation; this was accompanied with a marked decrease in collagenase and gelatinase activity from bovine nasal cartilage. The cholesterol pathway intermediate mevalonic acid reversed the simvastatin-mediated protection of cartilage degradation, and the expression and production of collagenase (MMP-1 and MMP-13) and gelatinase (MMP-2 and MMP-9). Statins also significantly decreased MMP-1 and MMP-13 expression in human articular cartilage and chondrocytes stimulated with IL-1+ OSM, and blocked the activation of critical proinflammatory signalling pathways required for MMP expression. The loss of the isoprenoid intermediate geranylgeranyl pyrophosphate due to statin treatment accounted for the inhibition of MMP expression and signalling pathway activation. Conclusions This study shows, for the first time, that lipophilic statins are able to block cartilage collagen breakdown induced by proinflammatory cytokines, by downregulating key cartilage-degrading enzymes. This demonstrates a possible therapeutic role for statins in acting as anti-inflammatory agents and in protecting cartilage from damage in joint diseases.
引用
收藏
页码:2189 / 2198
页数:10
相关论文
共 20 条
  • [1] Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix
    Collen, A
    Hanemaaijer, R
    Lupu, F
    Quax, PHA
    van Lent, N
    Grimbergen, J
    Peters, E
    Koolwijk, P
    van Hinsbergh, VWM
    BLOOD, 2003, 101 (05) : 1810 - 1817
  • [2] Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema
    Ohnishi, K
    Takagi, M
    Kurokawa, Y
    Satomi, S
    Konttinen, YT
    LABORATORY INVESTIGATION, 1998, 78 (09) : 1077 - 1087
  • [3] Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation
    Wong, BM
    Lumma, WC
    Smith, AM
    Sisko, JT
    Wright, SD
    Cai, TQ
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 69 (06) : 959 - 962
  • [4] Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis - Involvement of matrix metalloproteinase 3
    Blom, Arjen B.
    van Lent, Peter L.
    Libregts, Sten
    Holthuysen, Astrid E.
    van der Kraan, Peter M.
    van Rooijen, Nico
    van den Berg, Wim B.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (01): : 147 - 157
  • [5] Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation
    Karsdal, Morten Asser
    Sumer, Eren Ufuk
    Wulf, Helle
    Madsen, Suzi H.
    Christiansen, Claus
    Fosang, Amanda J.
    Sondergaard, Bodil-Cecilie
    ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1549 - 1558
  • [6] Experimental Resin Cements Containing Bioactive Fillers Reduce Matrix Metalloproteinase-mediated Dentin Collagen Degradation
    Osorio, Raquel
    Yamauti, Monica
    Sauro, Salvatore
    Watson, Thimoty E.
    Toledano, Manuel
    JOURNAL OF ENDODONTICS, 2012, 38 (09) : 1227 - 1232
  • [7] Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: Dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding
    Butler, Georgina S.
    Dean, Richard A.
    Tam, Eric M.
    Overall, Christopher M.
    MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (15) : 4896 - 4914
  • [8] Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells
    Aznavoorian, S
    Moore, BA
    Alexander-Lister, LD
    Hallit, SL
    Windsor, LJ
    Engler, JA
    CANCER RESEARCH, 2001, 61 (16) : 6264 - 6275
  • [9] Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation - The role of advanced glycation end products
    DeGroot, J
    Verzijl, N
    Wenting-Van Wijk, MJG
    Bank, RA
    Lafeber, FPJG
    Bijlsma, JWJ
    TeKoppele, JM
    ARTHRITIS AND RHEUMATISM, 2001, 44 (11): : 2562 - 2571
  • [10] Scavenger Receptor Class A Type I/II Determines Matrix Metalloproteinase-Mediated Cartilage Destruction and Chondrocyte Death in Antigen-Induced Arthritis
    van Lent, P. L. E. M.
    Hofkens, W.
    Blom, A. B.
    Grevers, L.
    Sloetjes, A.
    Takahashi, N.
    van Tits, L. J.
    Vogl, T.
    Roth, J.
    de Winther, M. P.
    van den Berg, W. B.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (10): : 2954 - 2965